Related Experiment Video
Updated: Oct 9, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
Non-invasive intravascular monitoring in the pediatric hemodialysis population
S R Jain1, L Smith, E D Brewer
1Renal Section, Baylor College of Medicine, Houston, Texas, USA.
Insights
Non-invasive monitoring of hematocrit (NIVM) reduces dialysis-associated morbidity (DAM) in pediatric hemodialysis (HD) patients, particularly those under 35 kg. This method helps manage fluid shifts and prevent adverse events during treatment.
Area of Science:
- Nephrology
- Pediatric Medicine
- Biomedical Engineering
Background:
- Assessing dry weight in pediatric hemodialysis (HD) patients is challenging due to difficulties in fluid shift detection and patient communication.
- Chronic fluid overload in pediatric HD patients can lead to severe complications like hypertension and left ventricular hypertrophy.
Purpose of the Study:
- To evaluate the efficacy of non-invasive monitoring of hematocrit (NIVM) in preventing dialysis-associated morbidity (DAM) in pediatric HD patients.
- To determine optimal ultrafiltration rates based on blood volume changes to minimize DAM.
Main Methods:
- A retrospective review of 200 pediatric HD treatments, comparing outcomes with and without NIVM.
- DAM was defined as any event requiring nursing intervention, such as hypotension or cramping.
- Analysis of blood volume changes in relation to event occurrence within specific time frames.
Main Results:
- The overall event rate for DAM was lower in the NIVM group (0.22 vs. 0.3, P = 0.07).
- NIVM significantly reduced the event rate in patients weighing less than 35 kg (0.25 vs. 0.47, P = 0.01).
- The rate of recurrent events was significantly lower with NIVM (P < 0.01).
Conclusions:
- Non-invasive monitoring of hematocrit (NIVM) is an effective strategy for decreasing dialysis-associated morbidity in pediatric HD patients.
- Maintaining blood volume changes below 8% per hour in the first hour and below 4% per hour thereafter is crucial for reducing DAM in this population.
Abstract:
Assessment of dry weight in pediatric hemodialysis (HD) patients is difficult, since small fluid shifts may result in dialysis-associated morbidity (DAM) and children may not verbalize complaints. Achieving dry weight is critical since chronic fluid overload can result in hypertension and left ventricular hypertrophy. To determine if non-invasive monitoring of hematocrit (NIVM) is useful in preventing DAM in pediatric HD patients, we reviewed 200 HD treatments performed with or without NIVM (no NIVM). DAM was defined as an "event" (e.g., hypotension, headache, cramping) that required nursing intervention. Patient age, weight, and gender were similar in both groups. Desired ultrafiltration was obtained in both groups. The event rate was lower in NIVM than no NIVM for all treatments (0.22 vs. 0.3, P = 0.07) and significantly lower in patients < 35 kg (0.25 vs. 0.47, P = 0.01). The second event rate (fraction of treatments with one event that had a subsequent event occurring at least 15 min later) was lower with NIVM (P < 0.01). For the NIVM group, events in the first 90 min occurred when blood volume changed > 8% per hour; 71% of events (43/60) at 90-240 min occurred when blood volume changed > 4% per hour. NIVM decreases DAM in pediatric HD patients, especially those < 35 kg. Ultrafiltration with blood volume change < 8% per hour is safe in the 1st h and < 4% after 1 h reduces DAM in children.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
